Webinar Overview
In drug discovery, we often use protein inhibitors as a strategy for therapeutic intervention, but the protein degrader’s mechanism of action can generate advantages over the traditional small-molecule inhibitors (SMIs) methodology.
In this webinar, we take an in-depth look at the degrader’s potential for enhanced potency and selectivity. We’ll discuss how to build a degrader and outline how to approach your customized PROTAC project. The webinar will conclude with a live Q&A session to wrap up any outlying questions that you may have.
Webinar Presenters
Simon Gilbert, PhD,
Research Leader, Biology
Charles River
Andrew Roupany, PhD
Research Leader, Chemistry
Charles River
Additional Webinars On Demand
- When Biology and Chemistry Collide: A Formula for HTS Success
- Designing a Drug for COVID-19: Considerations for Inhaled Therapeutics to Treat Respiratory Diseases
- Chemical CRISPR: A Targeted Protein Degradation Success Story
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.